Australia markets closed

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.62+0.16 (+2.48%)
At close: 04:00PM EDT
6.62 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-90,248
-96,015
-85,981
-72,188
-88,290
-
Depreciation & amortisation
1,831
2,581
2,408
2,964
3,922
-
Stock-based compensation
7,118
7,625
7,537
13,373
11,629
-
Change in working capital
-7,625
-6,337
-3,689
-23,041
16,160
-
Accounts receivable
-
0
110
-110
0
-
Accounts payable
-4,105
-764
-5,246
1,209
-3,431
-
Other working capital
-92,535
-95,695
-100,992
-79,045
-57,498
-
Other non-cash items
-
-
-18,485
-81
-
-
Net cash provided by operating activities
-91,377
-94,180
-97,977
-77,764
-56,599
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,158
-1,515
-3,015
-1,281
-899
-
Purchases of investments
-200,774
-117,428
-182,762
-141,249
-401
-
Sales/maturities of investments
135,866
128,632
212,811
51,444
7,900
-
Net cash used for investing activities
-66,061
9,689
59,157
-91,086
6,600
-
Cash flows from financing activities
Debt repayment
-
0
-66
0
0
-
Common stock issued
114,889
2,974
72,551
134,878
132,490
-
Other financing activities
-
-
-
-
-3,790
-2,102
Net cash used provided by (used for) financing activities
110,363
3,122
74,831
134,985
128,700
-
Net change in cash
-47,075
-81,369
36,011
-33,865
78,701
-
Cash at beginning of period
166,482
157,217
121,206
155,071
76,370
-
Cash at end of period
119,407
75,848
157,217
121,206
155,071
-
Free cash flow
Operating cash flow
-91,377
-94,180
-97,977
-77,764
-56,599
-
Capital expenditure
-1,158
-1,515
-3,015
-1,281
-899
-
Free cash flow
-92,535
-95,695
-100,992
-79,045
-57,498
-